Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00768794 · ClinicalTrials.gov registry record · NA
Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy
A NA study of Oral Candidiasis, sponsored by Summa Health System.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT00768794: Completed NA study of Oral Candidiasis, sponsored by Summa Health System.
NCT00768794 is a NA study of Oral Candidiasis that has completed, run by Summa Health System. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00768794, a NA study of Oral Candidiasis, has completed, sponsored by Summa Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effectiveness of using acidophilus to treat oral candidiasis (thrush) caused by radiation therapy to the head and neck region. This study will conducted in two parts. In the first part of the study, two participants will begin radiation therapy. When signs and symptoms of thrush are noted, such as smooth, creamy, white/yellow coating and/or patches on the tongue and inside of your mouth that are painful, you will begin taking acidophilus capsules twice each day until the last day of radiation therapy. The second part of the study is to determine if acidophilus is effective in preventing oral candidiasis (thrush) during radiation therapy to the head and neck region. In the second part of the study three participants will take acidophilus capsules twice each day beginning on the first day of radiation therapy and continuing until the last day of radiation therapy.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Acidophilus
- DIETARY_SUPPLEMENT Acidolphilus
Study Locations (1)
Ohio
- Summa Health System - Akron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-07 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT00768794 record still lists
NCT00768794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Oral Candidiasis appearing as the primary indexed condition, and to 2 interventions - of which Acidophilus is the first listed.
NCT00768794 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00768794 about?
NCT00768794 is a clinical study titled "Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy". The purpose of this study is to determine the effectiveness of using acidophilus to treat oral candidiasis (thrush) caused by radiation therapy to the head and neck region. This study will conducted in two parts. In the first part of the study, two participants will begin radiation therapy. When si...
What is the current status of trial NCT00768794?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2006-07. Estimated completion is 2010-09.
What conditions does trial NCT00768794 study?
This clinical trial studies the following conditions: Oral Candidiasis.
What interventions are being tested in trial NCT00768794?
The interventions under investigation include: Acidophilus (DIETARY_SUPPLEMENT), Acidolphilus (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00768794?
This trial is sponsored by Summa Health System, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00768794 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00768794's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia